Regeneron Pharmaceuticals
REGN
#318
Rank
$75.39 B
Marketcap
$732.27
Share price
-0.35%
Change (1 day)
22.06%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total assets

Total assets on the balance sheet as of June 2026 : $41.73 Billion USD

According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are $41.73 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$40.55 B7.41%
2024-12-31$37.75 B14.15%
2023-12-31$33.08 B13.23%
2022-12-31$29.21 B14.86%
2021-12-31$25.43 B48.19%
2020-12-31$17.16 B15.93%
2019-12-31$14.80 B26.17%
2018-12-31$11.73 B33.89%
2017-12-31$8.76 B25.68%
2016-12-31$6.97 B24.32%
2015-12-31$5.60 B46.16%
2014-12-31$3.83 B30.05%
2013-12-31$2.95 B41.84%
2012-12-31$2.08 B57.19%
2011-12-31$1.32 B21.49%
2010-12-31$1.08 B46.98%
2009-12-31$0.74 B2.34%
2008-12-31$0.72 B-22.65%
2007-12-31$0.93 B60.02%
2006-12-31$0.58 B38.16%
2005-12-31$0.42 B-10.49%
2004-12-31$0.47 B-1.34%
2003-12-31$0.47 B22.47%
2002-12-31$0.39 B-20.96%
2001-12-31$0.49 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$201.06 B 381.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$122.03 B 192.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
$95.63 B 129.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$147.30 B 252.98%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$32.08 B-23.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$5.55 B-86.68%๐Ÿ‡บ๐Ÿ‡ธ USA